Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 77

Sort by

Sort Order Select

Journal Articles

Lack of Benefit of Extended Vincristine and Dexamethasone Pulses during Maintenance Treatment of Childhood Acute Lymphoblastic Leukemia: A Multicenter Randomized Controlled Study of Chinese Children Cancer Group (CCCG)-ALL-2015

Blood (2019) 134 (Supplement_1): 2576.

https://doi.org/10.1182/blood-2019-128523

Published: 2019

Journal Articles

Therapy Related Myeloid Neoplasms- Clinical, Pathologic and Genetic Characteristics - a Single Center Experience

Dina Sameh Soliman, MD MB, MMSc, Ahmed Al-Sabbagh, MD, Shehab Fareed Mohamed, MD, Susanna Jane Akiki, PhD, Halima El-Omri, MD, Firyal Ibrahim, MD, Mohamed A Yassin, MBBS, MSc, Prem Chandra, PhD

Blood (2019) 134 (Supplement_1): 5169.

https://doi.org/10.1182/blood-2019-124951

Published: 2019

Journal Articles

Local Field Radiotherapy Induced Therapy Related Myeloid Neoplasms and Bone Marrow Suppression

Dina Sameh Soliman, MD MB, MMSc, Ahmad Al-Sabbagh, MD, Firyal Ibrahim, MD, Halima El-Omri, MD, Mohamed A Yassin, MBBS, MSc, Aliaa Amer, MD

Blood (2019) 134 (Supplement_1): 5113.

https://doi.org/10.1182/blood-2019-131683

Published: 2019

Journal Articles

Comparison of Clinical Evolution of Children with Sickle Cell Disease before and after Treatment with Hydroxyurea at Saint Damien Hospital, Tabarre-Haiti,2013-2018

Nora St Victor Dély, MD, Ofelia A. Alvarez, MD, Vanessa J Dor, MD, Emmeline Lerebours, MD

Blood (2019) 134 (Supplement_1): 2306.

https://doi.org/10.1182/blood-2019-124105

Published: 2019

Journal Articles

Methotrexate-Loaded Biodegradable Polymeric Micelles for Lymphoma Therapy in Mouse Model

Mengyao Wang, MD, Ying Qu, PhD, Zhiyong Qian, PhD, Ting Niu, MD PhD

Blood (2018) 132 (Supplement 1): 4181.

https://doi.org/10.1182/blood-2018-99-119151

Published: 2018

Journal Articles

Phase I/II Trial of Bendamustine, Ixazomib and Dexamethasone (BID) in Patients (pts.) with Relapsed/Refractory Multiple Myeloma (RRMM)

Binod Dhakal, MBBS, Anita D'Souza, MBBS, Mehdi Hamadani, MD, Carlos E. Arce-Lara, MD, Katrina Schroeder, Saurabh Chhabra, MD, Nirav N Shah, MD, Katelyn Gauger, Taylor Keaton, Marcelo C. Pasquini, MD, Parameswaran Hari, MBBS, MD

Blood (2018) 132 (Supplement 1): 1998.

https://doi.org/10.1182/blood-2018-99-110832

Published: 2018

Journal Articles

Clonal Selection in Therapy Related Myelodysplastic Syndromes Under Azacitidine Treatment

Anne Calleja, Chimene Moreilhon, PhD, Jean Michel Karsenti, MD, Lauris Gastaud, MD, Lionel Mannone, MD, Berengere Dadone, MD, Guillaume Robert, PhD, Patrick Auberger, PhD, Sophie Raynaud, MD PhD, Thomas Cluzeau, MDPhD

Blood (2017) 130 (Supplement 1): 5297.

https://doi.org/10.1182/blood.V130.Suppl_1.5297.5297

Published: 2017

Journal Articles

Ten-Day Decitabine Treatment in AML Associated with Reversible Non-Ischemic Cardiomyopathy

Bhavisha Patel, MD, Barac Ana, MD, Kelly W. Fitzpatrick, MD, Aarthi Shenoy, MD

Blood (2017) 130 (Supplement 1): 5032.

https://doi.org/10.1182/blood.V130.Suppl_1.5032.5032

Published: 2017

Journal Articles

Adaptive Reactivation of Signaling Pathways As a Novel Mechanism of Resistance to JAK Inhibitors in Ph-like ALL

Christian Hurtz, PhD, Sarah K Tasian, MD, Gerald Wertheim, MD PhD, Rachel Astles, BA, Alexis Zebrowski, BA, Alexander E. Perl, MD, Martin Carroll, MD

Blood (2016) 128 (22): 755.

https://doi.org/10.1182/blood.V128.22.755.755

Published: 2016

Journal Articles

Drug Sensitivity Across Acute Myeloid Leukemia Subtypes Using an in Vitro Assay

Levanto Schachter, DO, MSc, Irene M. Hutchins, MD, Jill Waalen, MD MPH, Carol Burian, CCRP, Darren Finlay, PhD, Kristiina Vuori, MD PhD, Giovanni Paternostro, MD PhD, Marin F. Xavier, MD, Carrie L. Costantini, MD, William E. Miller, MD, Jeffrey Andrey, MD, James Mason, MD

Blood (2016) 128 (22): 5208.

https://doi.org/10.1182/blood.V128.22.5208.5208

Published: 2016

Journal Articles

The Role of HOXA4 in Chronic Lymphocytic Leukaemia Progression and Response to Therapy

Timothy M Barrow, PhD, Laura Woodhouse, PhD, Gesa Junge, PhD, Susan J Tudhope, PhD, Charlotte Behardien, BSc, Jonathan P Wallis, MD, Helen J Marr, MD PhD, Scott R Marshall, MD, Nick Bown, PhD, Elaine Willmore, BSc, PhD, Gordon Strathdee, BSc, PhD

Blood (2016) 128 (22): 3924.

https://doi.org/10.1182/blood.V128.22.3924.3924

Published: 2016

Journal Articles

Philadelphia (Ph) Chromosome ( BCR-ABL1 fusion) As a Recurrent Genetic Abnormality Among Therapy-Related Acute Leukemia

Ibrahim Aldoss, MD, Tracey Stiller, Joo Y. Song, MD, Monzr M al Malki, MD, Haris Ali, MD, Amandeep Salhotra, MD, Samer K Khaled, MD, Ahmed Aribi, MD, Popsie Gaytan, Joyce L. Murata-Collins, PhD, David S. Snyder, MD, Anthony S. Stein, MD, Margaret O'Donnell, MD, Ryotaro Nakamura, MD, Joycelynne M. Palmer, PhD, Stephen J. Forman, MD, Guido Marcucci, MD, Vinod Pullarkat, MD

Blood (2016) 128 (22): 3974.

https://doi.org/10.1182/blood.V128.22.3974.3974

Published: 2016

Journal Articles

Bendamustine Treatment in Refractory or Relapsed T Cell Lymphomas: A Retrospective Multicenter Study

Blood (2015) 126 (23): 1505.

https://doi.org/10.1182/blood.V126.23.1505.1505

Published: 2015

Journal Articles

Eligibility Criteria Are Not Associated with Expected or Observed Adverse Events in Randomized Controlled Trials (RCTs) of Hematologic Malignancies

Abby Statler, MPH, MA, Tomas Radivoyevitch, PhD, Caitlin Siebenaller, PharmD, BCOP, Aaron T. Gerds, MD MS, Matt Kalaycio, MD, Eric Kodish, MD, Sudipto Mukherjee, MD PhD, Connie Cheng, PharmD, BCOP, Mikkael A. Sekeres, MD MS

Blood (2015) 126 (23): 635.

https://doi.org/10.1182/blood.V126.23.635.635

Published: 2015

Journal Articles

An Analysis of Prognostic Markers and the Performance of Scoring Systems in 1837 Patients with Therapy-Related Myelodysplastic Syndrome - a Study of the International Working Group (IWG-PM) for Myelodysplastic Syndromes (MDS)

Andrea Kuendgen, MD, Heinz Tuechler, Meritxell Nomdedeu, Guillermo Garcia-Manero, MD, Rami S. Komrokji, MD, Mikkael A. Sekeres, MD MS, Matteo Giovanni Della Porta, MD, Alan F List, MD, Mario Cazzola, Amy E. DeZern, MD MHS, Gail J. Roboz, MD, David P. Steensma, MD, Arjan A van de Loosdrecht, MD PhD, Arjan A van de Loosdrecht, MD PhD, Richard F. Schlenk, MD, Xavier Calvo, Sabine Blum, Arturo Pereira, Peter Valent, MD, Dolors Costa, Aristoteles Giagounidis, MD PhD, Luis Benlloch, Uwe Platzbecker, MD, Carmen Pedro, MD, Michael Lübbert, MD, Maria Teresa Cedena, Sigrid Machherndl-Spandl, MD, Maria Lopez-Pavia, MD, Detlef Haase, MD, Ana Africa Martin, Claudia D Baldus, MD, Montserrat Martínez de Sola, Reinhard Stauder, MD MSc, Brayan Merchan, MD, Claudia Mende, María Teresa Ardanaz, MD, Christina Ganster, Francesc Cobo, Thomas Schroeder, MD, Jordi Esteve, Rainer Haas, MD, Nomdedeu Benet, Peter L. Greenberg, MD, Ulrich Germing, MD, Guillermo Sanz, MD PhD

Blood (2015) 126 (23): 609.

https://doi.org/10.1182/blood.V126.23.609.609

Published: 2015

Journal Articles

Clinical Outcome of Therapy-Related Acute Myeloid Leukemia Is Strongly Related to Cytogenetic Analysis

Croix Fossum, BS, Rhett P. Ketterling, MD, Lindsey E. Roeker, Ajoy L. Dias, MD, Michelle Elliott, MD, William J. Hogan, MBChB, Mark R. Litzow, MD, Aref Al-Kali, MD

Blood (2015) 126 (23): 1401.

https://doi.org/10.1182/blood.V126.23.1401.1401

Published: 2015

Journal Articles

The Inhibition of Checkpoint Kinase 1 As a Promising Strategy to Increase the Effectiveness of Different Treatments in Acute Lymphoblastic Leukemia

Andrea Ghelli Luserna Di Rora, Ilaria Iacobucci, PhD, Enrica Imbrogno, Enrico Derenzini, MD, Anna Ferrari, PhD, Viviana Guadagnuolo, PhD, Valentina Robustelli, Simona Soverini, Cristina Papayannidis, MD PhD, Maria Chiara Abbenante, MD, Michele Cavo, MD, Giovanni Martinelli, MD PhD

Blood (2015) 126 (23): 2478.

https://doi.org/10.1182/blood.V126.23.2478.2478

Published: 2015

Journal Articles

Hypoalbuminemia Is Significantly Associated with Increased Clearance Time of High Doses of Methotrexate

Samantha N. Reiss, PharmD, Larry W. Buie, PharmD, BCOP, Nelly G. Adel, PharmD, BCOP, BCPS, Debra A. Goldman, MS, Sean Devlin, PhD, Dan Douer, MD

Blood (2015) 126 (23): 3711.

https://doi.org/10.1182/blood.V126.23.3711.3711

Published: 2015

Journal Articles

An Impdh Inhibitor, FF-10501 Possesses Activating Effects on Myeloid Differentiation As Well As Anti-Proliferation

Michiko Ichii, MD PhD, Motohiko Murase, MSc, Kensuke Komatsu, PhD, Motoki Saito, PhD, Jun Toda, MD, Kenji Oritani, MD PhD, Hiroyuki Iwamura, PhD, Yuzuru Kanakura, MD PhD

Blood (2015) 126 (23): 3679.

https://doi.org/10.1182/blood.V126.23.3679.3679

Published: 2015

Journal Articles

HDAC Inhibition Induces microRNA-182 Which Targets Rad51 Protein and Impairs Homologous Recombination Repair to Sensitize Cells to the Double Strand Break Inducing Nucleoside Analog, Sapacitabine in AML

Tzung-Huei Lai, PhD, Alma Zecevic, Brett Ewald, PhD, Liu Chaomei, Lara Rizzotto, PhD, Melanie Sulda, Dimitrios Papaioannou, MD, Ramiro Garzon, MD, William Plunkett, PhD, Deepa Sampath, PhD

Blood (2015) 126 (23): 3639.

https://doi.org/10.1182/blood.V126.23.3639.3639

Published: 2015

NARROW

Lack of Benefit of Extended Vincristine and Dexamethasone Pulses during Maintenance Treatment of Childhood Acute Lymphoblastic Leukemia: A Multicenter Randomized Controlled Study of Chinese Children Cancer Group (CCCG)-ALL-2015

Therapy Related Myeloid Neoplasms- Clinical, Pathologic and Genetic Characteristics - a Single Center Experience

Local Field Radiotherapy Induced Therapy Related Myeloid Neoplasms and Bone Marrow Suppression

Comparison of Clinical Evolution of Children with Sickle Cell Disease before and after Treatment with Hydroxyurea at Saint Damien Hospital, Tabarre-Haiti,2013-2018

Methotrexate-Loaded Biodegradable Polymeric Micelles for Lymphoma Therapy in Mouse Model

Phase I/II Trial of Bendamustine, Ixazomib and Dexamethasone (BID) in Patients (pts.) with Relapsed/Refractory Multiple Myeloma (RRMM)

Clonal Selection in Therapy Related Myelodysplastic Syndromes Under Azacitidine Treatment

Ten-Day Decitabine Treatment in AML Associated with Reversible Non-Ischemic Cardiomyopathy

Adaptive Reactivation of Signaling Pathways As a Novel Mechanism of Resistance to JAK Inhibitors in Ph-like ALL

Drug Sensitivity Across Acute Myeloid Leukemia Subtypes Using an in Vitro Assay

The Role of HOXA4 in Chronic Lymphocytic Leukaemia Progression and Response to Therapy

Philadelphia (Ph) Chromosome ( BCR-ABL1 fusion) As a Recurrent Genetic Abnormality Among Therapy-Related Acute Leukemia

Bendamustine Treatment in Refractory or Relapsed T Cell Lymphomas: A Retrospective Multicenter Study

Eligibility Criteria Are Not Associated with Expected or Observed Adverse Events in Randomized Controlled Trials (RCTs) of Hematologic Malignancies

An Analysis of Prognostic Markers and the Performance of Scoring Systems in 1837 Patients with Therapy-Related Myelodysplastic Syndrome - a Study of the International Working Group (IWG-PM) for Myelodysplastic Syndromes (MDS)

Clinical Outcome of Therapy-Related Acute Myeloid Leukemia Is Strongly Related to Cytogenetic Analysis

The Inhibition of Checkpoint Kinase 1 As a Promising Strategy to Increase the Effectiveness of Different Treatments in Acute Lymphoblastic Leukemia

Hypoalbuminemia Is Significantly Associated with Increased Clearance Time of High Doses of Methotrexate

An Impdh Inhibitor, FF-10501 Possesses Activating Effects on Myeloid Differentiation As Well As Anti-Proliferation

HDAC Inhibition Induces microRNA-182 Which Targets Rad51 Protein and Impairs Homologous Recombination Repair to Sensitize Cells to the Double Strand Break Inducing Nucleoside Analog, Sapacitabine in AML

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only